Most people have never heard of primary biliary cholangitis (PBC), but the progressive, rare cholestatic liver disease can ...

A new biotech is hitting the Boston scene with $50 million from Flagship Pioneering and a goal of preventing patients from ...

A copy of the R&D Day presentation can be found here.

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis — a primary driver of ...

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

but their specific roles in the progression of disease remain unknown. To address this ... Ammonia Build-Up Kills Liver Cells but Can Be Prevented Using Existing Drug Mar. 7, 2025 — High levels ...

Several comorbidities are associated with nonalcoholic fatty liver disease, including cardiovascular disease, type 2 diabetes, and sleep apnea. Comorbidities refer to having two or more coexisting ...

Cirrhosis is a progressive condition that puts both ... until they develop advanced symptoms. Over time, the disease keeps the liver from working properly and eventually causes liver failure.